Literature DB >> 22913976

Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012.

A Sisto1, F D'Ancona, M Meledandri, A Pantosti, G M Rossolini, A Raglio, R Serra, L Dematte, E Aiello, A Goglio.   

Abstract

Carbapenem-resistant Klebsiella pneumoniae has recently been reported as a new, multidrug-resistant nosocomial pathogen in several hospitals from various Italian regions. Through Micronet, a new Italian sentinel laboratory-based surveillance network, we studied the trend of non-susceptibility of K. pneumoniae to selected carbapenems (imipenem and/or meropenem) in 14 of the 15 hospitals participating in the network. Analysis of data from 1 January 2009 to 30 April 2012 revealed a statistically significant increasing trend (p<0.01) in the proportion of carbapenem non-susceptible K. pneumoniae isolates from clinical specimens (from 2.2 % in 2009 to 19.4% in 2012). The increase in the proportion of non-susceptibility was very large for isolates from the respiratory tract (from 5.3% in 2009 to 38.5% in 2012) and blood (from 5.4% in 2009 to 29.2% in 2012). The results demonstrate the urgent need in Italy for infection control, guidelines, antibiotic stewardship programmes and utilisation of surveillance systems, such as Micronet, which are capable of receiving data from hospitals in real time for many pathogens and types of clinical specimens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913976

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  10 in total

1.  Identification of capsular types in carbapenem-resistant Klebsiella pneumoniae strains by wzc sequencing and implications for capsule depolymerase treatment.

Authors:  Yi-Jiun Pan; Tzu-Lung Lin; Yi-Tsung Lin; Po-An Su; Chun-Tang Chen; Pei-Fang Hsieh; Chun-Ru Hsu; Ching-Ching Chen; Yu-Chia Hsieh; Jin-Town Wang
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

Review 2.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

3.  Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients.

Authors:  Motoi Ugajin; Kenichi Yamaki; Natsuko Hirasawa; Takanori Kobayashi; Takeo Yagi
Journal:  Clin Interv Aging       Date:  2014-02-11       Impact factor: 4.458

4.  Use of WHONET-SaTScan system for simulated real-time detection of antimicrobial resistance clusters in a hospital in Italy, 2012 to 2014.

Authors:  Alessandra Natale; John Stelling; Marcello Meledandri; Louisa A Messenger; Fortunato D'Ancona
Journal:  Euro Surveill       Date:  2017-03-16

5.  Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.

Authors:  Simone Iacchini; Michela Sabbatucci; Carlo Gagliotti; Gian Maria Rossolini; Maria Luisa Moro; Stefania Iannazzo; Fortunato D'Ancona; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Euro Surveill       Date:  2019-01

6.  Spread of Carbapenem-Resistant Klebsiella pneumoniae in Hub and Spoke Connected Health-Care Networks: A Case Study from Italy.

Authors:  Pamela Barbadoro; Arianna Dichiara; Daniele Arsego; Elisa Ponzio; Sandra Savini; Esther Manso; Marcello M D'Errico
Journal:  Microorganisms       Date:  2019-12-23

7.  Decolonization of carbapenem-resistant Klebsiella pneumoniae from the intestinal microbiota of model mice by phages targeting two surface structures.

Authors:  Ju-Yun Liu; Tzu-Lung Lin; Ching-Yu Chiu; Pei-Fang Hsieh; Yi-Tsung Lin; Li-Yin Lai; Jin-Town Wang
Journal:  Front Microbiol       Date:  2022-08-22       Impact factor: 6.064

8.  Longitudinal Assessment of Antimicrobial Susceptibility among Gram-Negative and Gram-Positive Organisms Collected from Italy as Part of the Tigecycline Evaluation and Surveillance Trial between 2004 and 2011.

Authors:  Stefania Stefani; Michael J Dowzicky
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-07

9.  Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa.

Authors:  Bin Cai; Roger Echols; Glenn Magee; Juan Camilo Arjona Ferreira; Gareth Morgan; Mari Ariyasu; Takuko Sawada; Tsutae Den Nagata
Journal:  Open Forum Infect Dis       Date:  2017-08-16       Impact factor: 3.835

10.  Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy.

Authors:  Daniela Loconsole; Marisa Accogli; Anna Lisa De Robertis; Loredana Capozzi; Angelica Bianco; Anna Morea; Rosanna Mallamaci; Michele Quarto; Antonio Parisi; Maria Chironna
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-06-01       Impact factor: 3.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.